Tag: FDA orphan designation

Orphan Drug Exclusivity: How Rare-Disease Medicines Get Market Protection

Orphan drug exclusivity gives pharmaceutical companies seven years of market protection for rare-disease treatments, encouraging development of drugs that would otherwise be unprofitable. Here's how it works, who benefits, and why it's controversial.